NeuroSense Therapeutics Ltd. (NRSN, NRSNW) (CIK 0001875091) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001213900-25-114111
- Form
- CORRESP
- Filer
- NeuroSense Therapeutics Ltd. (NRSN, NRSNW) (CIK 0001875091)
- CIK
- 0001875091
- Ticker
- NRSN, NRSNW
- Filed
- 2025-11-24
- SIC industry
- 2834
- HQ
- Herzliya, L3
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1875091/000121390025114111/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗